From the Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles; the VA Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles; Laughren Psychopharmacology Consulting, Rockville, Md.; and Mallinckrodt Pharmaceuticals, St. Louis.